Equity Overview
Price & Market Data
Price: $0.0₅1
Daily Change: $0.00 / 0.00%
Daily Range: $0.0₅1 - $0.0₅1
Market Cap: $3,213
Daily Volume: 400
Performance Metrics
1 Week: -99.00%
1 Month: -99.00%
3 Months: -99.00%
6 Months: -99.00%
1 Year: -99.00%
YTD: -99.00%
Details
Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.